Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Antibody targeting facilitates effective intratumoral siRNA nanoparticle delivery to HER2-overexpressing cancer cells.

Palanca-Wessels MC, Booth GC, Convertine AJ, Lundy BB, Berguig GY, Press MF, Stayton PS, Press OW.

Oncotarget. 2016 Feb 23;7(8):9561-75. doi: 10.18632/oncotarget.7076.

2.

Comparative efficacy of 177Lu and 90Y for anti-CD20 pretargeted radioimmunotherapy in murine lymphoma xenograft models.

Frost SH, Frayo SL, Miller BW, Orozco JJ, Booth GC, Hylarides MD, Lin Y, Green DJ, Gopal AK, Pagel JM, B├Ąck TA, Fisher DR, Press OW.

PLoS One. 2015 Mar 18;10(3):e0120561. doi: 10.1371/journal.pone.0120561. eCollection 2015.

3.

Extracellular matrix dynamics in hepatocarcinogenesis: a comparative proteomics study of PDGFC transgenic and Pten null mouse models.

Lai KK, Shang S, Lohia N, Booth GC, Masse DJ, Fausto N, Campbell JS, Beretta L.

PLoS Genet. 2011 Jun;7(6):e1002147. doi: 10.1371/journal.pgen.1002147. Epub 2011 Jun 23.

4.

Anti-CD22 antibody targeting of pH-responsive micelles enhances small interfering RNA delivery and gene silencing in lymphoma cells.

Palanca-Wessels MC, Convertine AJ, Cutler-Strom R, Booth GC, Lee F, Berguig GY, Stayton PS, Press OW.

Mol Ther. 2011 Aug;19(8):1529-37. doi: 10.1038/mt.2011.104. Epub 2011 May 31.

5.

Normally occurring NKG2D+CD4+ T cells are immunosuppressive and inversely correlated with disease activity in juvenile-onset lupus.

Dai Z, Turtle CJ, Booth GC, Riddell SR, Gooley TA, Stevens AM, Spies T, Groh V.

J Exp Med. 2009 Apr 13;206(4):793-805. doi: 10.1084/jem.20081648. Epub 2009 Mar 16.

6.

Impaired myelopoiesis in mice lacking the repressors of translation initiation, 4E-BP1 and 4E-BP2.

Olson KE, Booth GC, Poulin F, Sonenberg N, Beretta L.

Immunology. 2009 Sep;128(1 Suppl):e376-84. doi: 10.1111/j.1365-2567.2008.02981.x. Epub 2008 Oct 31.

7.

Role of genetic resistance in invasive pneumococcal infection: identification and study of susceptibility and resistance in inbred mouse strains.

Gingles NA, Alexander JE, Kadioglu A, Andrew PW, Kerr A, Mitchell TJ, Hopes E, Denny P, Brown S, Jones HB, Little S, Booth GC, McPheat WL.

Infect Immun. 2001 Jan;69(1):426-34.

8.

Guide to the assessment of percentage "impairment" of the back, neck and pelvis. Australasian College of Rehabilitation Medicine.

Winer CE, Booth GC, Henke P, Jones LE, Lee LA, Niall PD.

Med J Aust. 1992 Sep 21;157(6):412-4. No abstract available.

PMID:
1447995
9.

Erythrocyte membrane calcium binding in normotensive and hypertensive subjects.

Bing RF, Booth GC, Heagerty AM, Swales JD.

J Hypertens Suppl. 1986 Dec;4(6):S299-302.

PMID:
3475417
10.

Intermittent pressure cuffing for oedematous digits.

Booth GC, Robinson N, Faithfull D, Edwards M, Olbourne N.

Med J Aust. 1980 Feb 9;1(3):127-8.

PMID:
7378170
11.

Letter: Nerve grafting in leprosy.

McLeod JG, Hargrave JC, Gye RS, Pollard JD, Walsh JC, Little JM, Booth GC.

Lancet. 1976 Jan 10;1(7950):95-6. No abstract available.

PMID:
54621
12.

Nerve grafting in leprosy.

McLeod JG, Hargrave JC, Gye RS, Pollard JD, Walsh JC, Little JM, Booth GC.

Brain. 1975 Jun;98(2):203-12. No abstract available.

PMID:
1148815
13.

Nerve conduction studies in leprosy.

McLeod JG, Hargrave JC, Walsh JC, Booth GC, Gye RS, Barron A.

Int J Lepr Other Mycobact Dis. 1975 Jan-Mar;43(1):21-31.

PMID:
1171828
14.

Use of immunosuppressive agents in human nerve grafting.

Gye RS, Hargrave JC, Loewenthal J, McLeod JG, Pollard JD, Booth GC.

Lancet. 1972 Mar 25;1(7752):647-50. No abstract available.

PMID:
4125160

Supplemental Content

Loading ...
Support Center